Financhill
Back

Trevi Therapeutics Quote, Financials, Valuation and Earnings

Buy
69

TRVI
Trevi Therapeutics

Last Price:
2.76
Seasonality Move:
50.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Trevi Therapeutics Price Quote

$2.76
-0.01 (-2.82%)
(Updated: May 18, 2024 at 5:55 AM ET)

Trevi Therapeutics Key Stats

Buy
69
Trevi Therapeutics (TRVI) is a Buy

Day range:
$2.75 - $2.93
52-week range:
$0.97 - $4.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.7%

Volume:
67K
Avg. volume:
148.6K
1-year change:
13.06%
Market cap:
$195.1M
Revenue:
$0
EPS:
$-0.34

How Much Does Trevi Therapeutics Make?

Data Unavailable

Is Trevi Therapeutics Growing As A Company?

Data Unavailable

Trevi Therapeutics Stock Price Performance

What Is Trevi Therapeutics 52-Week High & Low?

Trevi Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Trevi Therapeutics?

Is Trevi Therapeutics Cash Flow Positive?

  • What Is TRVI Cash Flow From Operations?
    Cash flow from operations (TTM) is -$34M
  • What Is Trevi Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$6.2M
  • What Is Trevi Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $42.4M

Trevi Therapeutics Return On Invested Capital

Data Unavailable

Trevi Therapeutics Earnings Date & Stock Price

Trevi Therapeutics Competitors

Trevi Therapeutics Dividend Yield

Data Unavailable

Trevi Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -25.71%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 7.40
Upside from Last Price: 167.15%

Major Shareholders

  • How many TRVI shares are owned by institutional investors?
    50.7M TRVI shares are owned by institutional investors
  • How many TRVI shares are owned by insiders?
    1.1M TRVI shares are owned by insiders